{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:47Z","timestamp":1791357347572,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00520-011-1118-8","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T20:50:05Z","timestamp":1301086205000},"page":"375-384","source":"Crossref","is-referenced-by-count":15,"title":["Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study"],"prefix":"10.1007","volume":"20","author":[{"given":"Laura","family":"Amodeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorys","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Leombruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Biancofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Torta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"issue":"3","key":"1118_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-3223(03)00566-3","volume":"54","author":"D Spiegel","year":"2003","unstructured":"Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54(3):269\u2013282","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1118_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpsychores.2008.11.002","volume":"66","author":"M Hamer","year":"2009","unstructured":"Hamer M, Chida Y, Molloy GJ (2009) Psychological distress and cancer mortality. J Psychosom Res 66(3):255\u2013258, Epub 2009 Jan 16","journal-title":"J Psychosom Res"},{"issue":"6","key":"1118_CR3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1191\/0269216303pm781oa","volume":"17","author":"E Smith","year":"2003","unstructured":"Smith E, Gomm S, Dickens C (2003) Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med 17(6):509\u2013513","journal-title":"Palliat Med"},{"issue":"32","key":"1118_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jncimonographs\/lgh014","volume":"2004","author":"MJ Massie","year":"2004","unstructured":"Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004(32):57\u201371","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1118_CR5","doi-asserted-by":"crossref","unstructured":"Pirl WF (2004) Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr (32):32\u201339","DOI":"10.1093\/jncimonographs\/lgh026"},{"issue":"5","key":"1118_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s005200000195","volume":"9","author":"AF Angelino","year":"2001","unstructured":"Angelino AF, Treisman GJ (2001) Major depression and demoralization in cancer patients: diagnostic and treatment considerations. Support Care Cancer 9(5):344\u2013349","journal-title":"Support Care Cancer"},{"issue":"2","key":"1118_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00520-006-0145-3","volume":"15","author":"G Rodin","year":"2007","unstructured":"Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15(2):123\u2013136, Epub 2006 Oct 21","journal-title":"Support Care Cancer"},{"issue":"9632","key":"1118_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(08)60991-5","volume":"372","author":"V Strong","year":"2008","unstructured":"Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, McHugh G, Walker A, Sharpe M (2008) Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 372(9632):40\u201348","journal-title":"Lancet"},{"issue":"1","key":"1118_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00520-007-0269-0","volume":"16","author":"R Torta","year":"2008","unstructured":"Torta R, Siri I, Caldera P (2008) Sertraline effectiveness and safety in depressed oncological patients. Support Care Cancer 16(1):83\u201391, Epub 2007 Sep 14","journal-title":"Support Care Cancer"},{"issue":"9632","key":"1118_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(08)60968-X","volume":"372","author":"G Rodin","year":"2008","unstructured":"Rodin G (2008) Treatment of depression in patients with cancer. Lancet 372(9632):8\u201310","journal-title":"Lancet"},{"key":"1118_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.288.11.1403","volume":"288","author":"SA Bull","year":"2002","unstructured":"Bull SA, Hu XH, Hunkeler EM et al (2002) Discontinuation of use and switching of antidepressants: influence of patient\u2013physician communication. JAMA 288:1403\u20131409","journal-title":"JAMA"},{"key":"1118_CR12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0149-2918(00)83028-3","volume":"22","author":"CM Beasley Jr","year":"2000","unstructured":"Beasley CM Jr, Koke SC, Nilsson ME, Gonzales JS (2000) Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin Ther 22:1319\u20131330","journal-title":"Clin Ther"},{"key":"1118_CR13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4088\/JCP.v63n0811","volume":"63","author":"KA Kobak","year":"2002","unstructured":"Kobak KA, Taylor L, Katzelnick DJ et al (2002) Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence. J Clin Psychiatry 63:727\u2013732","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"1118_CR14","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0149-2918(03)80220-5","volume":"25","author":"PS Masand","year":"2003","unstructured":"Masand PS (2003) Tolerability and adherence issues in antidepressant therapy. Clin Ther 25(8):2289\u20132304","journal-title":"Clin Ther"},{"key":"1118_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archpsyc.58.1.55","volume":"58","author":"AS Young","year":"2001","unstructured":"Young AS, Klap R, Sherbourne CD, Wells KB (2001) The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 58:55\u201361","journal-title":"Arch Gen Psychiatry"},{"key":"1118_CR16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s002280000234","volume":"56","author":"JU Rosholm","year":"2001","unstructured":"Rosholm JU, Andersen M, Gram LF (2001) Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 56:923\u2013929","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1118_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/S1478951507000612","volume":"5","author":"H Onishi","year":"2007","unstructured":"Onishi H, Yamamoto W, Wada M, Nishida T et al (2007) Detection and treatment of akathisia in advanced cancer patients during adjuvant analgesic therapy with tricyclic antidepressants: case reports and review of the literature. Palliat Support Care 5(4):411\u2013414","journal-title":"Palliat Support Care"},{"issue":"6","key":"1118_CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.bp.107.048371","volume":"194","author":"LI Sinclair","year":"2009","unstructured":"Sinclair LI, Christmas DM, Hood SD, Potokar JP et al (2009) Antidepressant-induced jitteriness\/anxiety syndrome: systematic review. Br J Psychiatry 194(6):483\u2013490","journal-title":"Br J Psychiatry"},{"issue":"3","key":"1118_CR19","first-page":"CD002791","volume":"18","author":"C Barbui","year":"2007","unstructured":"Barbui C, Hotopf M, Freemantle N, Boynton J et al (2007) WITHDRAWN: treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev 18(3):CD002791","journal-title":"Cochrane Database Syst Rev"},{"key":"1118_CR20","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and statistical manual of mental disorders, fourth edition, text revision","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington"},{"key":"1118_CR21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382\u2013389","journal-title":"Br J Psychiatry"},{"key":"1118_CR22","unstructured":"Guy W. (1976) DOTES: dosage record and treatment emergent symptom scale. In: Rockville GW (ed) ECDEU assessment manual for psychopharmacology, rev. ed. National Institute of Mental Health Rockville, MD, USA."},{"key":"1118_CR23","unstructured":"Conti L. Gli effetti indesiderati dei trattamenti psicofarmacologici. (2000) In Conti L. \"Repertorio delle scale di valutazione in psichiatria\". S.E.E. (ed) Firenze, Italy. p. 1533\u20131544"},{"key":"1118_CR24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","volume":"344","author":"DL Musselman","year":"2001","unstructured":"Musselman DL, Lawson DH, Gumnick JF, Manatunga AK et al (2001) Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961\u2013966","journal-title":"N Engl J Med"},{"key":"1118_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"1118_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.141.1.45","volume":"141","author":"NP Kearns","year":"1982","unstructured":"Kearns NP, Cruickshank CA, McGuigan KJ, Riley SA, Shaw SP, Snaith RP (1982) A comparison of depression rating scales. Br J Psychiatry 141:45\u201349","journal-title":"Br J Psychiatry"},{"issue":"4","key":"1118_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.yic.0000130232.57629.46","volume":"19","author":"M Zimmerman","year":"2004","unstructured":"Zimmerman M, Posternak MA, Chelminski I (2004) Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 19(4):215\u2013220","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"1118_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s005200050241","volume":"7","author":"M Costantini","year":"1999","unstructured":"Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the hospital anxiety and depression scale. Support Care Cancer 7(3):121\u2013127","journal-title":"Support Care Cancer"},{"issue":"6","key":"1118_CR29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpsychires.2004.03.007","volume":"38","author":"M Zimmerman","year":"2004","unstructured":"Zimmerman M, Posternak MA, Chelminski I (2004) Derivation of a definition of remission on the Montgomery\u2013Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 38(6):577\u2013582","journal-title":"J Psychiatr Res"},{"key":"1118_CR30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355","journal-title":"Br J Med Psychol"},{"key":"1118_CR31","doi-asserted-by":"crossref","unstructured":"Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M (2010) Antidepressants for depression in physically ill people. Cochrane Database Syst Rev (3):CD007503. doi: 10.1002\/14651858.CD007503.pub2","DOI":"10.1002\/14651858.CD007503.pub2"},{"key":"1118_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6602949","volume":"94","author":"S Williams","year":"2006","unstructured":"Williams S, Dale J (2006) The effectiveness of treatment for depression\/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 94:372\u2013390","journal-title":"Br J Cancer"},{"key":"1118_CR33","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1200\/JCO.2003.08.025","volume":"21","author":"MJ Fisch","year":"2003","unstructured":"Fisch MJ, Loehrer PJ, Kristeller J, Passik S et al (2003) Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier oncology group. J Clin Oncol 21:1937\u20131943","journal-title":"J Clin Oncol"},{"key":"1118_CR34","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","volume":"21","author":"GR Morrow","year":"2003","unstructured":"Morrow GR, Hickok JT, Roscoe JA, Raubertas RF et al (2003) Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21:4635\u20134641","journal-title":"J Clin Oncol"},{"key":"1118_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-004-2175-1","volume":"89","author":"JA Roscoe","year":"2005","unstructured":"Roscoe JA, Morrow GR, Hickok JT, Mustian KM et al (2005) Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243\u2013249","journal-title":"Breast Cancer Res Treat"},{"key":"1118_CR36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0447.1996.tb09850.x","volume":"94","author":"D Razavi","year":"1996","unstructured":"Razavi D, Allilaire JF, Smith M, Salimpour A, Verra M et al (1996) The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 94:205\u2013210","journal-title":"Acta Psychiatr Scand"},{"key":"1118_CR37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.169.4.440","volume":"169","author":"K Heeringen Van","year":"1996","unstructured":"Van Heeringen K, Zivkov M (1996) Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 169:440\u2013443","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1118_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1012518831494","volume":"70","author":"G Pezzella","year":"2001","unstructured":"Pezzella G, Moslinger-Gehmayr R, Contu A (2001) Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 70(1):1\u201310","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1118_CR39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0885-3924(02)00379-2","volume":"23","author":"MA Weitzner","year":"2002","unstructured":"Weitzner MA, Moncello J, Jacobsen PB, Minton SJ (2002) A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. Pain Symptom Manage 23(4):337\u2013345","journal-title":"Pain Symptom Manage"},{"key":"1118_CR40","first-page":"25","volume":"19-1","author":"P Chi-Un","year":"2004","unstructured":"Chi-Un P, Kim Y-J, Won W-Y, Kim H-J et al (2004) Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study. Hum Psychopharmacol Clin Exp 19-1:25\u201329","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1118_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1992.tb04082.x","volume":"33","author":"JC Bloomer","year":"1992","unstructured":"Bloomer JC, Woods FR, Haddock RE, Lennard MS, Tucker T (1992) The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clin Pharmacol 33:521\u2013523","journal-title":"Br J Clin Pharmacol"},{"issue":"350","key":"1118_CR42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0447.1989.tb07176.x","volume":"80","author":"CM Kaye","year":"1989","unstructured":"Kaye CM, Haddock RE, Langley PF et al (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand 80(350):60\u201375","journal-title":"Acta Psychiatr Scand"},{"key":"1118_CR43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00003495-200262040-00010","volume":"62","author":"AJ Wagstaff","year":"2002","unstructured":"Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa Kl (2002) Paroxetine: an update of its use in psychiatric disorders in adults. Drugs 62:655\u2013703","journal-title":"Drugs"},{"issue":"2","key":"1118_CR44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v67n0217","volume":"67","author":"DL Musselman","year":"2006","unstructured":"Musselman DL, Somerset WI, Guo Y, Manatunga AK et al (2006) A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 67(2):288\u2013296","journal-title":"J Clin Psychiatry"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-011-1118-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1118-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T12:52:22Z","timestamp":1560084742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1118-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]}}}